Trexquant Investment LP

Position in SRRK — Scholar Rock Holding Corp

CIK 1633445 STAMFORD, CT

Position in SRRK

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,772,931

+$1,617,697 QoQ

Shares Held

76,748

+56.9% QoQ

Ownership

0.064%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 91.03689998436441.ToString("F0")% Shared 0.ToString("F0")% None 8.963100015635586.ToString("F0")%

Healthcare · as of Mar 31, 2026

Trexquant Investment LP holds $494,710,504 across 119 Biotechnology names. SRRK ranks #49 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	483,971	$24,585,726
2	ALNY	Alnylam Pharmaceuticals, Inc.	61,760	$20,434,531
3	ARWR	Arrowhead Pharmaceuticals, Inc.	277,114	$17,375,047
4	EXEL	Exelixis, Inc.	390,818	$16,762,184
5	HRMY	Harmony Biosciences Holdings, Inc.	594,850	$16,661,748
6	IONS	Ionis Pharmaceuticals Inc	213,645	$16,042,603
7	CNTA	Centessa Pharmaceuticals plc	390,951	$15,528,573
8	ASND	Ascendis Pharma A/S	65,517	$14,985,703

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,772,931	76,748	+56.9%	Shares	Sole	2026-05-15
2025-12-31	$2,155,234	48,927	-14.3%	Shares	Sole	2026-02-17
2025-03-31	$1,835,957	57,106	-15.9%	Shares	Sole	2025-05-14
2024-12-31	$2,936,107	67,934	-54.6%	Shares	Sole	2025-02-12
2024-09-30	$1,198,976	149,685	-45.1%	Shares	Sole	2024-11-12
2024-06-30	$2,272,382	272,795	+97.6%	Shares	Sole	2024-08-13
2024-03-31	$2,452,158	138,072	+91.0%	Shares	Sole	2024-05-14
2023-12-31	$1,358,958	72,285	+321.3%	Shares	Sole	2024-02-09
2022-09-30	$118,904	17,158	-37.0%	Shares	Sole	2022-11-14
2022-06-30	$149,404	27,214	+120.9%	Shares	Sole	2022-08-11
2022-03-31	$158,830	12,322	+59.4%	Shares	Sole	2022-05-13
2021-03-31	$391,652	7,731	—	Shares	Sole	2021-05-13
No filing history on record for this holder in this stock.